stockrowHealthEquity, Inc.
HQY Healthcare Health Information Services
HealthEquity, Inc.’s revenue for fiscal 2026 (year ended January 2026) was $1.3 billion, up 9.47% from fiscal 2025.
- Revenue
- +7.64%
- EPS
- +14.5%
- Free cash flow
- −3.44%
- Total debt
- −7.53%
Quarter to July 2026, against a year earlier
Follow HQY
Alert me
HealthEquity, Inc. (HQY) EPS (diluted)
HealthEquity, Inc.'s EPS (diluted) for fiscal 2026 was $2.46, up 125.7% from $1.09 in fiscal 2025. Over the twelve months to 31 July 2026 it was $2.77. Over the past ten years it has ranged from −$0.53 (fiscal 2022) to $2.46 (fiscal 2026) — the current reading is the highest in ten years. EPS (diluted) has risen for 4 consecutive fiscal years. HealthEquity, Inc. ranks 3rd of 42 Health Information Services companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2026 | $2.46 | 125.69% |
| FY2025 | $1.09 | 70.31% |
| FY2024 | $0.64 | — |
| FY2023 | −$0.31 | — |
| FY2022 | −$0.53 | — |
| FY2021 | $0.12 | (79.31%) |
| FY2020 | $0.58 | (50.43%) |
| FY2019 | $1.17 | 51.95% |
| FY2018 | $0.77 | 75.00% |
| FY2017 | $0.44 | 57.14% |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Jul 2026 | $0.78 | (4.88%) |
| Apr 2026 | $0.82 | 41.38% |
| Jan 2026 | $0.58 | (1.69%) |
| Oct 2025 | $0.59 | (13.24%) |
| 43 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| HQY HealthEquity, Inc. | $2.77 |
| BTSG BrightSpring Health Services, Inc. compare | $1.85 |
| HNGE Hinge Health Inc. compare | $1.28 |
| DOCS Doximity, Inc. compare | $0.72 |
| WAY Waystar Holding Corp. compare | $0.69 |
| PRVA Privia Health Group, Inc. compare | $0.27 |
| SDGR Schrodinger, Inc. compare | −$0.79 |
| TEM Tempus AI, Inc. compare | −$1.06 |
| HTFL Heartflow, Inc. compare | −$1.83 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on HQY
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement